Market Place
Sourcing Support
Abraxis Bioscience on Health Canada Inspection List
07 Dec 2022 //
HEALTH CANADA
Abraxis failed to proactively address repeat media fill contamination issues
10 Nov 2022 //
RAPS
Abraxis Bioscience LLC Receives FDA Warning Letter
08 Nov 2022 //
FDA
Abraxis files plea against Sun pharm Adv Research alleging infringementof patent
20 Aug 2019 //
INDIAINFOLINE
Initial Treatment of People With a Type of Advanced Squamous Lung Cancer
20 Mar 2018 //
GENE.COM
Tocagen Appointed Martin Duvall as Chief Executive Officer
02 Nov 2016 //
PR NEWSWIRE
Abraxis denied patent for combination of Taxane
12 Jan 2016 //
FINANCIAL EXPRESS
Soon-Shiong`s NantKwest is spending more on stock buybacks than R&D
14 Nov 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.